Epic 30-day unplanned readmission risk score for Patients at High Risk of Unplanned Readmission

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Wake Forest University Health Sciences, Winston-Salem, NC
Patients at High Risk of Unplanned Readmission+1 More
Epic 30-day unplanned readmission risk score - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The objective is to assess the implementation of a computerized clinical decision support (cCDS) tool for identifying patients at high risk of unplanned readmission who could benefit from existing care programs aimed at reducing readmissions

Eligible Conditions

  • Patients at High Risk of Unplanned Readmission
  • Unplanned Hospital Readmissions

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Patients at High Risk of Unplanned Readmission

Study Objectives

15 Primary · 1 Secondary · Reporting Duration: Day 30

Day 30
30 day Readmission Rate
Number of transitional and supportive care services (TSC) referrals by providers in the Control group
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Care Plus
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Faith Health
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Geriatrics Transitional Care
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - High Risk Readmission Program (HRI)
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Mobile Health Clinic
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Population Health Pharmacy
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Care Plus
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Faith Health
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Geriatrics Transitional Care
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Mobile Health Clinic
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Population Health Pharmacy
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group- High Risk Readmission Program (HRI)
Provider Satisfaction Score

Trial Safety

Safety Progress

1 of 3

Other trials for Patients at High Risk of Unplanned Readmission

Trial Design

2 Treatment Groups

control group (CG)
1 of 2
intervention group (IG)
1 of 2
Active Control
Experimental Treatment

12000 Total Participants · 2 Treatment Groups

Primary Treatment: Epic 30-day unplanned readmission risk score · No Placebo Group · N/A

intervention group (IG)
Behavioral
Experimental Group · 1 Intervention: Epic 30-day unplanned readmission risk score · Intervention Types: Behavioral
control group (CG)NoIntervention Group · 1 Intervention: control group (CG) · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: day 30
Closest Location: Wake Forest University Health Sciences · Winston-Salem, NC
2008First Recorded Clinical Trial
1 TrialsResearching Patients at High Risk of Unplanned Readmission
423 CompletedClinical Trials

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,100 Previous Clinical Trials
1,117,025 Total Patients Enrolled
Donna Williams, MDPrincipal InvestigatorWake Forest University Health Sciences

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a patient of AHWFBH.
You must be at least 18 years old.\n

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.